US Stock MarketDetailed Quotes

CTOR Citius Oncology

Watchlist
  • 0.852
  • -0.124-12.69%
Close Nov 22 16:00 ET
  • 0.914
  • +0.061+7.21%
Post 17:51 ET
60.76MMarket Cap-3704P/E (TTM)

About Citius Oncology Company

Citius Oncology, Inc. is a pharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma. The company was founded on March 1, 2021 and is headquartered in Cranford, NJ.

Company Profile

SymbolCTOR
Company NameCitius Oncology
Listing DateDec 8, 2022
Founded2021
CEOMr. Leonard L. Mazur
MarketNASDAQ
Fiscal Year Ends12-31
Address11 Commerce Drive,1st floor
CityCranford
ProvinceNew Jersey
CountryUnited States of America
Zip Code07016

Company Executives

  • Name
  • Position
  • Salary
  • Leonard L. Mazur
  • Chairman of the Board and Chief Executive Officer
  • --
  • Dr. Myron Czuczman, M.D.
  • Chief Medical Officer
  • --
  • Jaime Bartushak
  • Chief Financial Officer and Treasurer
  • --
  • Myron Z. Holubiak
  • Director and Secretary
  • --
  • Carol Webb
  • Independent Director
  • --
  • Robert J. Smith
  • Independent Director
  • --
  • Dr. Eugene Holuka
  • Independent Director
  • --
  • Suren G. Dutia
  • Independent Director
  • --
  • Joel D. Mayersohn
  • Independent Director
  • --
  • Dennis M. McGrath, C.P.A.
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data